Pseudomonas aeruginosa was the most frightening pathogen that emergence in health facilities with increasing antibiotic resistance. Nanoparticles have reported as non-antibiotic therapeutic agents, that are highly effective in the treatment of P. aeruginosa infections. Combination therapy of nanoparticles and antibiotics considered an alternative therapeutic approach for restoring antibiotic activity. To achieve that goal, we used the synthetic silver nanoparticles in a combined form with ciprofloxacin against MDR P. aeruginosa. Fifty bacterial isolates that collected from different infection sites were confirmed as P. aeruginosa by detection of algD gene and Exotoxin A genes. Antibiotic sensitivity of P. aeruginosa strains was assessed by single diskdiffusion method. The most prevelant phenotype among P. aeruginosa were recorded. The synthetic nanoparticles AgNPs and ZnONPs were tested against all P. aeruginosa strains. minimum inhibitory conc (MIC) of ciprofloxacin and AgNPS was determined using microdilution method for 24 selected P. aeruginosa strains and in the range from 160-1280, 6-12mg/l, respectively. In vitro, the synergistic activity of ciprofloxacin and AgNPs was achieved in all combinations. Our finding approved that combination therapy depend on using nanoparticles considered a promising tool used to restore the activity of antibiotics.
Introduction
Pseudomonas aeruginosa is a dangerous opportunistic nosocomial pathogen. P. aeruginosa infections are common in hospitalized patients. it can be occurred in many anatomic sites like urinary tract, skin, ears, heart valves, bones, eyes, and subcutaneous tissue of serious infection as urinary tract infection, pneumonia, eye infection (keratitis), otitis, skin infection (folliculitis), septicemia, osteomyelitis, respiratory infection and wound infection especially patient with burn wounds. (Murry et al., 2002 and Hoge et al., 2010 ) spore forming bacteria with high mortality and morbidity rates in humans. (Gabra et al., 2012) . P. aeruginosa is widely distributed in nature present in soil, water, various types of vegetation throughout the world, respiratory equipment, disinfectants, sinks, taps, and mops in the hospitals (Murray et al., 2002 and Todar, 2011) .
Excessive use of antibiotics accelerates the development of multidrug-resistant P. aeruginosa isolates, which lead to the ineffectiveness of the antibiotic therapy. (Hirsch and Tam, 2010) . P. aeruginosa has resistance to many antibiotics that already used like aminoglycosides, quinolones, and β-lactams. Speert, 2000 and Lister et al., 2009) .), so the development of new antibiotics or alternative therapy for the treatment of P. aeruginosa infections is needed for patients who have infections resistant to conventional antibiotics. Chatterjee et al., (2016) have reported several non-antibiotic therapeutic, which is highly effective in the treatment of P. aeruginosa infections. These approaches include phage therapy, inhibition of quorum sensing and bacterial lectins, use of iron chelation, nanoparticles, antimicrobial peptides, electrochemical scaffolds, and vaccine strategy. These therapeutic approaches can be used instead of antibiotics or in combination with antibiotics .
Nanoparticles of heavy metals as metal oxides have a high ability to interact with pathogenic microorganisms and deactivate or eliminate the virus or bacteria especially P. aeruginosa (Salehi et al, 2013; and Chauhan et al., 2014) . Effectiveness of nanoparticles as antimicrobial agents was due to small doses used, low toxicity and lack of side effects (Lara et al., 2010) and its bactericidal activity depends on their concentration, their stability, and size of nanoparticles (Raghupathi et al., 2011) .
Traditionally silver nanoparticles AgNPs have a strong antibacterial activity, medical and technological applications (Edwards-Jones, 2009 ). Many studies proposed a different antibacterial mechanism of AgNPs synthesized using different methods, Singh et al., (2008) proposed that the production of reactive oxygen species that damage bacterial cell membranes.While; Rai et al., (2009) demonstrated the interaction of AgNPs with sulfur-containing membrane proteins.
On the other hand, Sawai, (2003) found that ZnO NPs have a strong antibacterial activity illustrated by direct contact of ZnO-NPs with cell walls of bacteria and destruction of the cell wall with the liberation of Zn+2 ions. There are several mechanisms of antibacterial activity of ZnO NPs including:
1) The induction of reactive oxygen including hydrogen peroxide [H2O2].
2) The destruction of cell membranes and the interaction of ZnO NPs with intracellular components of the cell. In general, cell membrane of bacteria has pores in nanometer which facilitate the entrance of ZnO NPs through these pores (Li et al., 2011) .
The aim of this study was to the impact of silver and zinc nanoparticles as an alternative therapeutic strategy in combination with ciprofloxacin antibiotics on multidrug resistance Pseudomonas aeruginosa clinical strains.
Material and Methods:

Study design
Fifty clinical bacterial isolates were collected from the New Kasr El-Ainy teaching hospital. Fifty consecutive P. aeruginosa isolates from clinically significant infections sites were collected including pus specimens, blood cultures, pleural fluid, urine, ascitic fluid, sputum, and Central Venous Line. The study was conducted from (January 2015 -January 2016). Identification to the genus level was done by a traditional microbiological method and it was confirmed by algD gene detection and Exotoxin A (ETA) using the sequences of the primers in Table 1 . 
Condition of the PCR : the reaction mixtures were subjected to Biometra UNO-thermoblock cycler using the following program: 
Number of cycles
Antibiotics susceptibility test:
Antibiotics susceptibility test was determined for P. aeruginosa strains (1.5×10 ˆ8) CFU/ml using standard disc diffusion method (Bauer et al., 1966) and according to the recommendation of CLSI document M02-A12 (CLSI 2015) in Cation-adjusted Mueller-Hinton agar (CA-MHA) (Oxoid, UK). All fifty clinical P. aeruginosa strains were tested for resistance to 14 commercially antibiotic discs; imipenem (10 µg), meropenem (10 µg), cefotaxime (30 µg), cefturoxime (30 µg), ciprofloxacin (5 µg), ceftriaxone (30 µg), colistin (10 µg), polymyxin (300 u), amikacin (30 µg), levofloxacin (5 µg), ceftazidime (30 µg), gentamicin (10 µg), ampicillin-sulbactam (10/10µg), amoxicillin/clavulanic acid (10/10µg) that selected according to CLSI guidelines . The standard strains of P. aeruginosa ATCC 15442 and E. coli ATCC 25922 were used to confirm the results.
Nanoparticles synthesis:
Silver nanoparticles (AgNPs) and Zinc oxid nanoparticles (ZnO NPs) were synthesized and prepared in Nano-Tech Egypt Company according to Pacholski et al., ( 2002) ; Beek et al,. (2005) and Pal et al., (2009) .
Determination of Minimum Inhibitory Concentrations (MICs)
MIC of ciprofloxacin (Sigma-Aldrich), Silver nanoparticles and Zinc oxide nanoparticles for 24 clinical selected MDR P.aeruginosa strains (1.5×10 ˆ5 CFU/ml) determined by broth microdilution method in Cation-adjusted Muller Hinton Broth (CA-MHB) (Oxoid, USA) according to (EUCAST, 2000) and (CLSI 2015) . MIC was performed in 96-well microtitre plates. CA-MHB containing serial of two-fold dilutions of ciprofloxacin, silver nanoparticles (3 -200 mg/l), and zinc oxide nanoparticles (7.8-2000 mg/l) were prepared.
Combination of ciprofloxacin antibiotic with silver nanoparticles against Pseudomans aeruginosa clinical strains by using Checkerboard method:
The dynamic checkerboard method was performed to evaluate the interaction of silver nanoparticles and zinc oxide nanoparticles in combination with ciprofloxacin (Bajaksouzian et al., 1997; Mackay et al., 2000 and Petersen et al., 2006) against 24 selected clinical P. aeruginosa strains. Organisms, antibiotic, and nanoparticles concentrations were prepared as described for the MIC determination using microtitre plates. To evaluate the effect of the combination the fractional inhibitory concentration (FIC) index was calculated for antibiotic and nanoparticles using the following formula:
FIC index= FIC A +FIC B FIC A = MIC of drug A in combination/MIC of drug A alone
FIC B = MIC of drug B in combination/MIC of drug B alone
The FIC indices were interpreted as: Synergy (of the joint action of two antimicrobial agents that when tacked together to increase each other effectiveness) = FIC ≤ 0.5 Additive or indifferent (no interaction means that an effect in which two antimicrobial agents produce a total effect the same as the sum of the individual effects) = FIC >0.5 ≤ 4.0 Antagonism (Opposition of action; counteraction or contrariety action) = FIC > 4.0.
After determining the MIC of silver NPs and antibiotic alone and together in combination, the percentage of growth inhibition for P. aeruginosa in comparison with positive control was calculated using the following equation (Bayroodi and Jalal, 2016) GI%=100-OD at the presence of antibacterial agent/OD of positive control×100 The statistical method:
The results of the percentage of growth inhibition of ciprofloxacin and silver nanoparticlles alone and in combination together are expressed as mean± standard error means (SEM). Every experiment was repeated three times. All data were analyzed and compared utilizing one-way ANOVA Duncan test 1995 by using SAS 2004 v.9 and differences with p < 0.05 were considered significant (Duncan, 1955 , SAS, 2004 .
Results
A total of Fafity bacterial isolates were collected from the microbiology laboratory in Al-Kasr Al-Ainy Hospitals from January 2015 to January 2016. The number of collected isolates were distributed according to infection sites (Fig. 1) . P. aeruginosa strains were predominating in pus culture followed by sputum and urine culture, however, blood culture , central venous line, Ascetic fluid and Pleural fluid were recorded as lowest infection sites for P. aeruginosa.
Infection sites
Figure. 1. Prevalence of P. aeruginosa according to infection sites
Molecular identification of clinical Pseudomonas aeruginosa using Polymerase Chain Reaction (PCR):
Fifty clinical bacterial isolates that primarily identified as Pseudomonas genus were further confirmed as Pseudomonas aeruginosa using molecular detection of algD GDP mannose and exotoxin A genes that is characteristic for P. aeruginosa using conventional PCR technique at amplification size 520 bp and 396 bp, respectively (Fig.2) 
Nanoparticles synthesis
Ag and Zn nanoparticles were synthesized with average size 19 ± 2 nm and average size 20 ± 5 nm, respectively. AgNPs and ZnO NPs have spherical shape (Fig.3) .
Antibiotic susceptibility test:
P. aeruginosa strains were recorded as resistance to three or more antibiotics. These degrees of resistance was confirmed to all clinical P. aeruginosa strains as following, P. aeruginosa was resistance to β-lactam, aminoglycosides, and fluoroquinolones, and no resistance showed to colistin. The high resistance rate in strains was recorded against ceftazidime (CAZ) 96%, cefotaxime (CTX) 92%, while the resistance rate exceeds 40% for both Ciprofloxacin (CIP) and Levofloxacin (LEV) (48%). On the other hand, Colistin (CT) showed a higher inhibitory effect (100%) against 50 clinical P. aeruginosa strains while Polymyxin (PB) recorded 98% inhibitory effect against 49 P. aeruginosa strains. Based on antimicrobial susceptibility test, twenty-four MDR P. aeruginosa resistant to ciprofloxacin subsequently was selected for further study. (Figure. 4) . 
Determination of minimal inhibitory concentration (MIC) of Ciprofloxacin and Silver nanoparticles against selected clinical P. aeruginosa strains:
Our data clarify that the highest inhibition for growth by ciprofloxacin was significantly (p < 0.05) achived for twelve P. aeruginosa strains (more than 99%), ten strains were significantly inhibited at 320 mg/l and two inhibited at 1280 mg/l. However, the highest inhibition for growth by silver nanoparticles was recorded for (Table 1) . On the other hand, our results represented that zinc oxide nanoparticles have no effect on 24 clinical P. aeruginosa strains, even with increasing the ZnO NPs concentration until 2000 mg/l.
Figure. 4. Sensitivity index of clinical P. aeruginosa strains
Combination of ciprofloxacin antibiotic with silver nanoparticles:
A combination of ciprofloxacin and silver nanoparticles considered a promising approach, synergistic action was achieved according to FIC index in all combinations used. Our results showed the activity of ciprofloxacin was increased in the presence of Ag-NPs against the tested strains. Table 2 summries the decreasing in the concentration of ciprofloxacin with 2 fold change for the majority of the P. aeruginosa strains and 3 fold change for only 6 P. aeruginosa strains. For silver nanoparticles concentration, the fold change was 2 for all P. aeruginosa strains. 
Discussion
Pseudomonas aeruginosa is a Gram-negative bacterium that develops the emergence of resistant to multiple antibiotics and responsible for the high rate of morbidity and mortality. The excessive antibiotic administrative leading to the emergence of multidrug-resistant (MDR) forms of P. aeruginosa that is regarded as -red-alert‖ that supports the need for monitoring antibiotic consumption, diagnosis, prevention, and the misuse of antibiotics. (Cassir et al., 2014) .
Most of P. aeruginosa strains were recovered from the pus culture 46% followed by sputum 22% and urine culture 14%, however, blood culture 6% and Central Venous Line, Ascetic fluid and Pleural fluid were recorded as lowest infection sites 4%. On the other hand, other studies reported that Pseudomonas is most commonly isolated from the respiratory tract followed by wound culture, urine and blood (Clark et al., 2003) . In addition, Thaden etal., (2017) reported that the most common sources of P. aeuruginosa are in respiratory tract 25% and urinary tract 19% followed by central venous catheter and skin culture .
Our data confirm the fact that supporting the emergence of resistance in all 50 P. aeruginosa collected from different infection sites with variation in the resistance rate and that results consistency with the previous study on P. aeruginosa used traditional antibiotics with continuous increasing resistance. (Hancock and Lehrer, 1998; Hancock and Speert, 2000) . Colistin is considered a promising antibiotic that still has higher sensitivity against P. aeruginosa as proposed in our study and compatible with Walkty and co-works, 2009 ).
The identification of P. aeruginosa is very easy but due to excessive antibiotic administration in the patients as children, the throat swab was chosen instead of sputum, the negative results can be noticed that lead to use some interstice genes target P. aeruginosa diagnoses as algD gene and Exotoxin A, the former codes for GDP mannose dehydrogenase, a vital enzyme in alginate synthesis pathway in P. aeruginosa at 520-bp PCR product (Deretic et al., 1987; Govan & Deretic 1996; Da Silva et al., 1999 and Xu et al., 2004) .
Exotoxin A (ETA) amplification at 396-bp region was detected in all tested P. aeruginosa strains, Exotoxin A is a 66 KDa protein that acts as a major virulence factor of P. aeruginosa, that is very toxic and can inhibit eukaryotic protein biosynthesis, similarly to toxins of diphtheria (Wolfgang et al., 2003; Al-Daraghi and Husamuldeen, 2013) . This approach is in agreement with other studies which provided evidence that detection of algD GDP mannose gene and Exotoxin A (ETA) can be used as a simple and specific method for identifying P. aeruginosa.
AgNPs have diverse applications due to their antibacterial activity and other biocompatible properties (Chernousova and Epple, 2013) . Several studies stated that AgNPs can be widely synthesized in numerous ways such as physical, chemical, photochemical, irradiation, laser, green synthesis and biological methods (Iravani, 2014) .
The antimicrobial activity of synthesized nanoparticles depends greatly on the size, shape and surface modification by various capping agents. Studies postulated that as the nanoparticle diameter decrease, the antibacterial activity of AgNPs increase and that was confirmed with our study where AgNPs with average size 19 ± 2 nm, showed a great effect on all tested P. aeruginosa strains at MIC 6-12 mg/L. Morones et al., 2005 , Panacek et al., 2006 , Zhang et al., 2014 . Divya et al., 2019 study the antibacterial activity of AgNPs sized (30-50) nm against P. aeruginosa and the MIC of P. aeruginosa was at 30-40 mg/l. The effect of shape was shown in our results, spherical AgNPs have a great antimicrobial activity on all tested P. aeruginosa that was inconsistence with other studies postulated that triangular or hexagonal AgNPs show better antibacterial activity than spherical AgNPs (El-Zahry et al., 2015; Singh et al., 2015) .
Various reports have been providing the shreds of evidence that all synthesis methods of silver nanoparticles were used as a powerful tool against multidrug-resistant bacteria, a chemical method as showed by Lara et al., 2010; Rai et al., 2012. In addition, Kora and Arunachalam, (2011) showed that silver nanoparticles synthesized by UV photo-reduction method are showing promising antibacterial activity on P. aeruginosa at very low concentrations. Saleh and Attia, (2016 ) showed a high antimicrobial activity of bio-AgNPs synthesized using orange peels against Salmonella Typhi and S. Typhimurium.
On the other hand, no interaction appeared when spherical ZnO NPs applied with average size 20 ± 5 nm ,This result is agreement with Niakan et al., (2019) who found that zinc oxide nanoparticles did not cause any inhibition for Pseudomonas growth. Although Yousef, et al., (2012 ) who found that ZnO NPs have the lowest effect of pathogenic strains used. In our study, the principle for using inorganic oxides ZnO NPs as antimicrobial agents is that they contain environmentally safe mineral elements essential to humans and have strong activity (Yousef, et al., 2012) .
In addition, Bayroodi and Jalal, (2016) reported that standard P. aeruginosa strains were more susceptible to ZnO NPs than clinical P. aeruginosa strains with MIC values of 93.7 and 375 mg/l, respectively. These differences may be attributed to strains used as recorded by Yousef and colleges, (2012) and the differences in the preparation methods of ZnO NPs. Other probable cause may be due to the size of ZnO NPs, where in Saadat, et al. (2013) have used ZonONPs in the range from 30-90 nm also Aysaa ; Salman, (2016) used ZnO NPs 29 nm when compared with our results sized 20 ± 5 nm.
The antimicrobial activitiy of biologically synthesized AgNPs were assessed with commercially available antibiotics against bacteria , the highest synergistic effect was observed with ampicillin and AgNPs combination against E. coli than when used chloramphenicol, erythromycin, and kanamycin (Fayaz et al., 2010) ,
In similar studies, AgNP treatment also showed synergistic effects that with the antibiotics polymixin B and rifampicin, and an additive effect with tigecycline against carbapenem A. baumannii isolates. On the other hand, on the combination with antibiotics, the synergistic action increased as suggested by (Habash et al. 2014) .
Depending on the previous results, we used silver nanoparticles in combination with ciprofloxacin to exhibit the synergistic effect on the clinical P. aeruginosa strains. The combination of antibiotics with nanoparticles was a promising approach to restore the activity of antibiotics with the lowest concentration instead of discovering new antibiotics and avoid the toxicity of synthetic chemicals.
